{"company": {"org_id": "T000062537", "org_name_cn": "北京凯因科技股份有限公司", "org_short_name_cn": "凯因科技", "org_name_en": "Beijing Kawin Technology Share-Holding Co.,Ltd.", "org_short_name_en": "Kawin", "main_operation_business": "病毒及免疫性疾病领域创新药物研发、生产、销售。", "operating_scope": "　　技术开发、技术咨询、技术转让、技术服务；货物进出口、技术进出口、代理进出口；设备租赁；物业管理；销售医疗器械Ⅰ、Ⅱ类；生产治疗用生物制品(人干扰素a2b注射液、注射用重组人干扰素a2b、人干扰素a2b阴道泡腾片、培集成干扰素a-2注射液、重组人干扰素a2a注射液)、小容量注射剂、冻干粉针剂、片剂、硬胶囊剂、颗粒剂；销售第Ⅲ类医疗器械。(市场主体依法自主选择经营项目，开展经营活动；销售第Ⅲ类医疗器械。以及依法须经批准的项目，经相关部门批准后依批准的内容开展经营活动；不得从事国家和本市产业政策禁止和限制类项目的经营活动。)", "district_encode": "110115", "org_cn_introduction": "北京凯因科技股份有限公司的主营业务是病毒及免疫性疾病领域创新药物研发、生产、销售。公司的主要产品是抗病毒/免疫调节药品、其他。", "legal_representative": "周德胜", "general_manager": "周德胜", "secretary": "王湛", "established_date": 1219161600000, "reg_asset": 170944422.0, "staff_num": 600, "telephone": "86-10-67892271", "postcode": "100176", "fax": "86-10-67892271", "email": "ir@kawin.com.cn", "org_website": "www.kawin.com.cn", "reg_address_cn": "北京市大兴区北京经济技术开发区荣京东街6号3号楼", "reg_address_en": null, "office_address_cn": "北京市大兴区北京经济技术开发区荣京东街6号3号楼", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1612713600000, "provincial_name": "北京市", "actual_controller": "周德胜 (8.02%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "周德胜", "executives_nums": 15, "actual_issue_vol": 42460000.0, "issue_price": 18.98, "actual_rc_net_amt": 725866141.0000001, "pe_after_issuing": 60.19, "online_success_rate_of_issue": 0.02997154, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}